WHO has urged people at risk to keep up with their vaccinations with boosters. IMAGE: A healthcare worker administers a dose of iNCOVACC, an intranasal vaccine as a booster dose for a senior......
After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology......
A parliamentary committee has stressed the urgent need to evolve strategies for development of next-generation vaccines and recommended that the Union health ministry encourage vaccine development......
Prime Minister Narendra Modi arrived in Washington, DC on Wednesday on the second leg of his maiden state visit to the United States during which he will hold bilateral talks with President Joe......
Eminent British-Indian Cardiologist Dr Aseem Malhotra, who has been leading international calls for the suspension of mRNA COVID-19 vaccines, said on Tuesday that Oxford-AstraZeneca's jab,......
The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech ......
The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred......
History shows us that even effective vaccines could have unknown side effects that could develop over time, warns former Cabinet Secetary K M Chandrasekhar. On July 2, the Indian Council of......
Bharat Biotech started work on developing a vaccine against Zika way back in 2014, but the timing of its announcement has created a flutter in the market. When Bharat Biotech recently......
Unlike many of his peers in corporate houses, Kumar doesn't have an MBA but says that hardly matters, as he has been lucky to have got great on-the-job experience, such as during his stint in Asia......